What is the level of liabilities of 2Seventy Bio this year?
2Seventy Bio has a debt balance of 268.7 M USD this year.
In 2025, 2Seventy Bio's total liabilities amounted to 268.7 M USD, a -13.36% difference from the 310.13 M USD total liabilities in the previous year.
2Seventy Bio's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating 2Seventy Bio's financial stability, operational efficiency, and long-term viability.
By comparing 2Seventy Bio's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
2Seventy Bio's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Shifts in 2Seventy Bio’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
2Seventy Bio has a debt balance of 268.7 M USD this year.
The liabilities of 2Seventy Bio have increased by -13.36% dropped compared to the previous year.
High liabilities can pose a risk for investors of 2Seventy Bio, as they can weaken the company's financial position and impair its ability to meet its obligations.
Low liabilities mean that 2Seventy Bio has a strong financial position and is able to meet its obligations without overburdening its finances.
An increase in liabilities of 2Seventy Bio can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
A decrease in the liabilities of 2Seventy Bio can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
Some factors that can influence the liabilities of 2Seventy Bio include investments, acquisitions, operating costs, and sales development.
The liabilities of 2Seventy Bio are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
To change its liabilities, 2Seventy Bio can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
Over the past 12 months, 2Seventy Bio paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, 2Seventy Bio is expected to pay a dividend of 0 USD.
The current dividend yield of 2Seventy Bio is .
2Seventy Bio pays a quarterly dividend. This is distributed in the months of .
2Seventy Bio paid dividends every year for the past 0 years.
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
2Seventy Bio is assigned to the 'Health' sector.
To receive the latest dividend of 2Seventy Bio from 10/4/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/4/2025.
The last dividend was paid out on 10/4/2025.
In the year 2024, 2Seventy Bio distributed 0 USD as dividends.
The dividends of 2Seventy Bio are distributed in USD.
Our stock analysis for 2Seventy Bio Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of 2Seventy Bio Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.